Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1997 4
1998 5
1999 3
2000 8
2001 6
2002 9
2003 6
2004 9
2005 9
2006 8
2007 15
2008 11
2009 15
2010 11
2011 11
2012 14
2013 13
2014 21
2015 8
2016 11
2017 10
2018 7
2019 11
2020 8
2021 6
2022 2
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

224 results

Results by year

Filters applied: . Clear all
Page 1
First-line selective internal radiotherapy plus chemotherapy versus chemotherapy alone in patients with liver metastases from colorectal cancer (FOXFIRE, SIRFLOX, and FOXFIRE-Global): a combined analysis of three multicentre, randomised, phase 3 trials.
Wasan HS, Gibbs P, Sharma NK, Taieb J, Heinemann V, Ricke J, Peeters M, Findlay M, Weaver A, Mills J, Wilson C, Adams R, Francis A, Moschandreas J, Virdee PS, Dutton P, Love S, Gebski V, Gray A; FOXFIRE trial investigators; SIRFLOX trial investigators; FOXFIRE-Global trial investigators; van Hazel G, Sharma RA. Wasan HS, et al. Lancet Oncol. 2017 Sep;18(9):1159-1171. doi: 10.1016/S1470-2045(17)30457-6. Epub 2017 Aug 3. Lancet Oncol. 2017. PMID: 28781171 Free PMC article. Clinical Trial.
[Zd 1839 "Iressa"].
Meric JB, Faivre S, Monnerat C, Adi Vago N, Le Chevalier T, Armand JP, Raymond E. Meric JB, et al. Among authors: faivre s. Bull Cancer. 2000 Dec;87(12):873-6. Bull Cancer. 2000. PMID: 11174115 Free article. Review. French.
MEK in cancer and cancer therapy.
Neuzillet C, Tijeras-Raballand A, de Mestier L, Cros J, Faivre S, Raymond E. Neuzillet C, et al. Among authors: faivre s. Pharmacol Ther. 2014 Feb;141(2):160-71. doi: 10.1016/j.pharmthera.2013.10.001. Epub 2013 Oct 9. Pharmacol Ther. 2014. PMID: 24121058 Review.
Cancer wars: natural products strike back.
Basmadjian C, Zhao Q, Bentouhami E, Djehal A, Nebigil CG, Johnson RA, Serova M, de Gramont A, Faivre S, Raymond E, Désaubry LG. Basmadjian C, et al. Among authors: faivre s. Front Chem. 2014 May 1;2:20. doi: 10.3389/fchem.2014.00020. eCollection 2014. Front Chem. 2014. PMID: 24822174 Free PMC article. Review.
New trials and results in systemic treatment of HCC.
Reig M, da Fonseca LG, Faivre S. Reig M, et al. Among authors: faivre s. J Hepatol. 2018 Aug;69(2):525-533. doi: 10.1016/j.jhep.2018.03.028. Epub 2018 Apr 11. J Hepatol. 2018. PMID: 29653122 Review.
Clinical Impact of Genomic Diversity From Early to Advanced Hepatocellular Carcinoma.
Nault JC, Martin Y, Caruso S, Hirsch TZ, Bayard Q, Calderaro J, Charpy C, Copie-Bergman C, Ziol M, Bioulac-Sage P, Couchy G, Blanc JF, Nahon P, Amaddeo G, Ganne-Carrie N, Morcrette G, Chiche L, Duvoux C, Faivre S, Laurent A, Imbeaud S, Rebouissou S, Llovet JM, Seror O, Letouzé E, Zucman-Rossi J. Nault JC, et al. Among authors: faivre s. Hepatology. 2020 Jan;71(1):164-182. doi: 10.1002/hep.30811. Epub 2019 Aug 12. Hepatology. 2020. PMID: 31206197
[PI3K-AKT-mTOR pathway and cancer].
Coutte L, Dreyer C, Sablin MP, Faivre S, Raymond E. Coutte L, et al. Among authors: faivre s. Bull Cancer. 2012 Feb 1;99(2):173-80. doi: 10.1684/bdc.2011.1384. Bull Cancer. 2012. PMID: 21742593 Free article. Review. French.
224 results